Phase 1 OCD Trial, Recruiting NCT07113665 Sponsor: Sunnybrook Health Sciences Centre Condition: OCD
Back to Ocd

Phase 1 OCD Trial, Recruiting

NCT07113665
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 65 years old (inclusive)
  • You are willing and able to give your consent to take part and can attend the required study visits, as agreed by both the study psychiatrist and surgeon
  • You have been diagnosed with Anorexia Nervosa along with OCD and/or Major Depressive Disorder, as defined by standard psychiatric guidelines
  • Your condition has not responded to previous treatments, shown by at least one of the following: your illness has lasted more than 10 years with no more than 3 months of healthy weight recovery; you have had at least 3 attempts at specialist hospital-based treatment without lasting success; or you have needed emergency or involuntary refeeding at least twice over at least 2 years due to medical deterioration
  • You are able to understand and agree to the study's terms and make your own medical decisions

Who may not be able to join:

  • You have an unstable or serious heart condition, such as recent heart attack (within 6 months), certain heart failure, uncontrolled high blood pressure, or are on certain heart medications
  • You have a metal implant or device in your body (such as a pacemaker) that is not safe for MRI scanning, or you cannot fit in an MRI machine
  • Your blood tests show problems with bleeding or blood clotting, including a low platelet count or abnormal clotting levels
  • You have had a stroke or bleeding in the brain within the last 6 months, or have a history of bleeding in the brain
  • You have sleep apnea that is not being treated or controlled
  • You are taking blood-thinning or anti-clotting medications (such as warfarin or aspirin) within one week before the procedure, or certain other medications that increase bleeding risk within one month before the procedure
  • You are unable or unwilling to lie still on your back for a long period of time during the treatment
  • You have taken part in another clinical trial in the last 30 days
  • You are unable to communicate with the study team
  • You have significant problems with memory or thinking
  • You have a history of psychosis
  • You have a known or newly discovered brain tumour
  • You are currently pregnant or breastfeeding
  • You have had a problem with alcohol or drug misuse in the last 6 months
  • You have a medical condition affecting how your body processes food or digestion (such as diabetes)
  • Your Body Mass Index (BMI) is below 13 (confirm with trial site if unsure how to calculate this)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 416-480-6954

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Registry
ClinicalTrials.gov
Start date
1 August 2025
Est. completion
1 August 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Safety and Feasibility of MRgFUS Capsulotomy in Patients with Treatment-Refractory Anorexia Nervosa

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov